Haha - and sit around the boardroom table looking at the cash burn?
Printable View
Close at 31.5
That seems awfully low
I have chased answers across every contact platform that I could. In the limited response I received, and these were all by phone, Kaiser won't even go as far as to confirm that they are even in negotiation with PEB about anything, anywhere, anytime. They're one superbly non-leaky ship! Sorry, I've drawn a big blank.
It appears to be common practice for large organisations to not reveal any connection to a vendor UNTIL something has been made official from that large organisation. Kaiser won't be unique to this.
In a somewhat small comparison, I've done hundreds of searches on websites using key words, knowing full well other associated parties to that business, and nothing comes up on the search. This is even for established connections, so you can imagine in a case where an established connection is not official that there would be silence of the highest order.
Appreciate your due diligence on this Hectorplains (a phone call is a very pragmatic step); we're all keen to see what eventuates.
https://www.nzx.com/announcements/318301
"Numbers generally in line with expectations".
Except that NOT one number met expectations!
No wonder sp down to 31c.
This bit is quite funny if not comical:
o The revenue number in the financial accounts for FY18 will be lower
than under the previous revenue accounting standard:
Under the previous accounting standard as used by Pacific Edge for FY17
financial results, revenue was recognised when tests were performed. This per
test revenue was set using an average of the historic per test revenue that
had been received from a large number of tests completed, for these patients
to date. With the change to the new standard, where revenue for these US
customers will be recognised when the cash is received, there will be a
reduction in the reported sales revenue for these US tests. The change will
mean that Pacific Edge will no longer report accrued test revenue for the US
component of the revenue.
This bit is actually very worrysome if you are a PEB holder:
Pacific Edge's FY18 plan included a small contribution to the
FY18 revenue from Kaiser Permanente however the Company has not yet generated
any sales from Kaiser Permanente. The commercial agreement continues to move
forward however this is taking longer than anticipated to finalise. In
addition, early sales to the Veterans Administration have been lower than
expected.
One good thing there shouldn’t be any bad debts under the new reporting standards ....cause all the bills stay in their ‘billing and reimbursement process’
And cash burn ~$18m ...hmmm